A single sperm donor carrying a rare cancer-causing genetic mutation has fathered nearly 200 children across Europe. The man, known as Donor 7069 or "Kjeld," had the mutation in his sperm, which is extremely rare, occurring in just 1 in 5,000 to 1 in 20,000 cases.
The investigation, led by French oncologist Edwige Kasper, uncovered that some of these children have already died, while many others are expected to develop deadly cancers. The mutation in question affects the TP53 gene, which plays a crucial role in preventing cancer by suppressing cell division and triggering cell death when a cell is beyond repair.
The offspring of Donor 7069 are at risk of developing various types of cancers, including brain, blood, bone, soft tissue, adrenal glands, and breast cancers. According to Kasper's findings, those who carry the mutation have up to a 90% chance of developing cancer by age 60, with half developing cancer by age 40.
The donor began donating sperm in Copenhagen in 2005, when he was a student, without knowing that he carried the rare mutation. His sperm was used in 67 fertility clinics across 14 countries, including Denmark, Belgium, Spain, Greece, Germany, Ireland, Poland, Albania, and Kosovo. While the true number of offspring is expected to be higher than the 197 children identified so far.
Kasper and her team are now working to identify and contact all of these children to ensure they can access critical monitoring and screening, which could increase their chances of survival. The investigation highlights the importance of genetic screening in fertility clinics and raises concerns about the risks associated with using sperm from individuals carrying rare mutations.
The investigation, led by French oncologist Edwige Kasper, uncovered that some of these children have already died, while many others are expected to develop deadly cancers. The mutation in question affects the TP53 gene, which plays a crucial role in preventing cancer by suppressing cell division and triggering cell death when a cell is beyond repair.
The offspring of Donor 7069 are at risk of developing various types of cancers, including brain, blood, bone, soft tissue, adrenal glands, and breast cancers. According to Kasper's findings, those who carry the mutation have up to a 90% chance of developing cancer by age 60, with half developing cancer by age 40.
The donor began donating sperm in Copenhagen in 2005, when he was a student, without knowing that he carried the rare mutation. His sperm was used in 67 fertility clinics across 14 countries, including Denmark, Belgium, Spain, Greece, Germany, Ireland, Poland, Albania, and Kosovo. While the true number of offspring is expected to be higher than the 197 children identified so far.
Kasper and her team are now working to identify and contact all of these children to ensure they can access critical monitoring and screening, which could increase their chances of survival. The investigation highlights the importance of genetic screening in fertility clinics and raises concerns about the risks associated with using sperm from individuals carrying rare mutations.